Sight Sciences, Inc.
SGHT • NASDAQ
Sight Sciences, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Paul Badawi, with a market cap of $209.5M.
CEOPaul Badawi
Next Earnings
Upcoming earnings announcement for Sight Sciences, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.20
Revenue Estimate
$18.6M
Earnings History
Past 12 earnings reports for Sight Sciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | -$0.08Est: -$0.15 | +46.7% | $20.4MEst: $20.3M | +0.2% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.16Est: -$0.26 | +38.5% | $19.9MEst: $17.5M | +13.7% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.23Est: -$0.27 | +14.8% | $19.6MEst: $18.2M | +7.8% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.28Est: -$0.23 | -21.7% | $17.5Est: $16.5M | -100.0% | 10-Q |
| Mar 5, 2025 | Q4 2024 | -$0.23Est: -$0.18 | -27.8% | $19.1MEst: $19.0M | +0.4% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.22Est: -$0.21 | -4.8% | $20.2MEst: $20.4M | -1.2% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$0.25Est: -$0.30 | +16.7% | $21.4MEst: $21.4M | +0.1% | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.33Est: -$0.28 | -17.9% | $19.3MEst: $18.4M | +4.8% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.22Est: -$0.32 | +31.3% | $18.8MEst: $18.9M | -0.9% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.27Est: -$0.32 | +15.6% | $20.0MEst: $21.6M | -7.3% | — |
| Aug 3, 2023 | Q2 2023 | -$0.30Est: -$0.34 | +11.8% | $23.5MEst: $22.4M | +4.8% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.35Est: -$0.39 | +10.3% | $18.8MEst: $18.9M | -0.2% | — |